How accurate is dynamic contrast-enhanced MRI in the assessment of renal glomerular filtration rate? A critical appraisal

✍ Scribed by Iosif Mendichovszky; Michael Pedersen; Jørgen Frøkiær; Thomas Dissing; Nicolas Grenier; Peter Anderson; Kieran McHugh; Qing Yang; Isky Gordon

• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 113 KB
• Volume: 27
• Category: Article
• ISSN: 1053-1807
• DOI: 10.1002/jmri.21313

✦ Synopsis

Abstract

Purpose

To evaluate the current literature to see if the published results of MRI‐glomerular filtration rate (GFR) stand up to the claim that MRI‐GFR may be used in clinical practice. Claims in the current literature that Gadolinium (Gd) DTPA dynamic contrast enhanced (DCE) MRI clearance provides a reliable estimate of glomerular filtration are an overoptimistic interpretation of the results obtained. Before calculating absolute GFR from Gd‐enhanced MRI, numerous variables must be considered.

Materials and Methods

We examine the methodology in the published studies on absolute quantification of MRI‐GFR. The techniques evaluated included the dose and volume of Gd‐DTPA used, the speed of injection, acquisition sequences, orientation of the subject, re‐processing, conversion of signal to concentration and the model used for analysis of the data as well as the MRI platform.

Results

Claims in the current literature that using DCE MRI “Gd DTPA clearance provides a good estimate of glomerular filtration” are not supported by the data presented and a more accurate conclusion should be that “no MRI approach used provides a wholly satisfactory measure of renal GFR function.”

Conclusion

This study suggests that DCE MRI‐GFR results are not yet able to be used as a routine clinical or research tool. The published literature does not show what change in DCE MRI‐GFR is clinically significant, nor do the results in the literature allow a single DCE MRI‐GFR measurement to be correlated directly with a multiple blood sampling technique. J. Magn. Reson. Imaging 2008. © 2008 Wiley‐Liss, Inc.